Is semaglutide cost-effective at closing the gap for Aboriginal and Torres Strait Islander Australians with cardiovascular disease and obesity without type 2 diabetes?

Semaglutide 是否具成本效益於改善患有心血管疾病及肥胖但無第二型糖尿病的澳洲原住民與托雷斯海峽島民的健康差距？